Acuta Capital Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-320,897
Closed -$1.28M 66
2016
Q1
$1.28M Sell
320,897
-886,829
-73% -$3.75M 0.72% 30
2015
Q4
$6.81M Sell
1,207,726
-672,278
-36% -$3.76M 3.26% 11
2015
Q3
$10.5M Buy
+1,880,004
New +$10.2M 6.11% 2

Other funds holding EXEL

Acuta Capital Partners's EXEL Position: Q2 2016 in Review

Acuta Capital Partners sold out of Exelixis (EXEL) in Q2 2016, closing a stake of 320,897 shares — an estimated $1.28M sold.

Acuta Capital Partners first reported a position in EXEL in Q3 2015 and held it in 3 quarters. The position peaked at $10.5M in Q3 2015. 166 funds tracked by Wall St. Rank hold EXEL as of Q2 2016.

  • Acuta Capital Partners reported no remaining Exelixis position as of Q2 2016 after selling out during the quarter.
  • Acuta Capital Partners sold 320,897 Exelixis shares in Q2 2016, an estimated $1.28M.
  • Acuta Capital Partners first reported a position in Exelixis in Q3 2015 and held it in 3 quarters.
  • Acuta Capital Partners's Exelixis position peaked at $10.5M in Q3 2015.
  • 166 funds tracked by Wall St. Rank held Exelixis as of Q2 2016.

Based on Acuta Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.